Back

Type 2 diabetes and atrial fibrillation: triangulation of observational, genetic, and trial evidence

30 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Prevalence and incidence of atrial fibrillation: risk stratification Prevalence and Incidence of Atrial Fibrillation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Adam Von Ende

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Postoperative atrial fibrillation as a marker of atrial myopathy in aortic stenosis: a prospective surgical cohort analysis
Doctor L. Cristin (Quebec, CA)
Abstract Slides
Presentation thumbnail
POAF duration modifies long-term stroke prediction by the CHA₂DS₂-VASc score after cardiac surgery
Doctor A. Taseva Vasileva (Skopje, MK)
Abstract Slides
Presentation thumbnail
Panoramic vs. empiric mapping in the diagnosis and treatment of persistent atrial fibrillation - meta analysis
Doctor R. Gagyi (Szeged, HU)
Abstract Slides
Presentation thumbnail
Identification of the mapping-based voltage-derived parameter for accurate arrhythmia outcome prediction in patients undergoing a first PVI
Doctor T. Huang (Lucerne, CH)
Abstract Slides
Presentation thumbnail
Sex differences in thromboembolic risk and anticoagulant management in patients with non-valvular atrial fibrillation: a systematic review
Miss V. Khan (GB)
Abstract Slides

Access the full session

Session thumbnail
Prevalence and incidence of atrial fibrillation: risk stratification

The Event

Event poster

ESC Congress 2026

30 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Diabetes mellitus and atrial fibrillation-the burden of pur century?
2 March 2019
thumbnail
Congress Presentation
Adherence and discontinuation of sglt2-inhibitors and glp1-r agonists in patients with type 2 diabetes with and without cardiovascular disease
27 August 2022
thumbnail
Congress Presentation
Causal pathways linking type 2 diabetes and glycemic traits to cerebrovascular outcomes: a comprehensive Mendelian randomization analysis
20 March 2026
thumbnail
Congress Presentation
Nation-wide GWAS meta-analysis reveals new genetic locus for early-onset atrial fibrillation
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources